These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25656607)

  • 21. The Association of
    Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
    In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
    Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
    J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
    Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
    Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MMP-2 (-1306 C/T) Polymorphism Affects Serum Matrix Metalloproteinase (MMP)-2 Levels and Correlates with Chronic Obstructive Pulmonary Disease Severity: A Case-Control Study of MMP-1 and -2 in a Tunisian Population.
    Bchir S; Nasr HB; Anes AB; Benzarti M; Garrouch A; Tabka Z; Chahed K
    Mol Diagn Ther; 2016 Dec; 20(6):579-590. PubMed ID: 27412345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis.
    Kang S; Zhao X; Xing H; Wang N; Zhou R; Chen S; Li W; Zhao J; Duan Y; Sun D; Li Y
    Environ Mol Mutagen; 2008 Apr; 49(3):226-31. PubMed ID: 18288718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
    Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.
    Wu CY; Wu MS; Chen YJ; Chen CJ; Chen HP; Shun CT; Chen GH; Huang SP; Lin JT
    Eur J Cancer; 2007 Mar; 43(4):799-808. PubMed ID: 17236757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
    Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer.
    Yaykaşli KO; Kayikçi MA; Yamak N; Soğuktaş H; Düzenli S; Arslan AO; Metın A; Kaya E; Hatıpoğlu ÖF
    Turk J Med Sci; 2014; 44(5):839-43. PubMed ID: 25539555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion.
    Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B
    Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder.
    Bobińska K; Szemraj J; Czarny P; Gałecki P
    J Affect Disord; 2016 Nov; 205():119-129. PubMed ID: 27434116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinase-2, -9, -12, and tissue inhibitor of metalloproteinase 2 gene polymorphisms and cutaneous expressions in patients with Behçet's disease.
    Park KS; Min Y; Park SR; Kim EH; Lee DJ; Bang D; Lee ES
    Tissue Antigens; 2012 May; 79(5):333-9. PubMed ID: 22428754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship of metalloproteinase gene polymorphisms and lung cancer.
    Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
    J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
    Sharma KL; Misra S; Kumar A; Mittal B
    Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease.
    Horne BD; Camp NJ; Carlquist JF; Muhlestein JB; Kolek MJ; Nicholas ZP; Anderson JL
    Am Heart J; 2007 Oct; 154(4):751-8. PubMed ID: 17893005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase-2 -735C/T polymorphism is associated with resistant hypertension in a specialized outpatient clinic in Brazil.
    Sabbatini AR; Barbaro NR; de Faria AP; Ritter AMV; Modolo R; Correa NB; Brunelli V; Pinho C; Fontana V; Moreno H
    Gene; 2017 Jul; 620():23-29. PubMed ID: 28390988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples.
    Pesta M; Holubec L; Topolcan O; Cerna M; Rupert K; Holubec LS; Treska V; Kormunda S; Elgrova L; Finek J; Cerny R
    Anticancer Res; 2005; 25(5):3387-91. PubMed ID: 16101153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
    Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian cancer cell invasion.
    Hu X; Li D; Zhang W; Zhou J; Tang B; Li L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1537-43. PubMed ID: 22832979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Association of Matrix Metalloproteinase-8 Promoter Genotypes in Breast Cancer.
    Hsiao CL; Liu LC; Shih TC; Chuang CL; Chen GL; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Way TD; Chung JG; Bau DT
    Anticancer Res; 2018 Apr; 38(4):2181-2185. PubMed ID: 29599337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.